Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesus Guinea

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Mycopathologia|July 11, 2024
Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining ChallengesMaiken Cavling Arendrup, Jesus Guinea, Joseph Meletiadis
International Journal of Antimicrobial Agents|December 7, 2010
New antifungal agents for the treatment of candidaemiaPatricia Muñoz, Jesus Guinea, Loreto Rojas, et al.
International Journal of Antimicrobial Agents|December 17, 2008
Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new dataPatricia Muñoz, Jesus Guinea, Marta Torres Narbona, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 11, 2020
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by TrichophytonMaiken C Arendrup, Gunnar Kahlmeter, Jesus Guinea, et al.
Current Opinion in Infectious Diseases|November 3, 2017
Emerging multidrug-resistant Candida speciesArnaldo L Colombo, João N de Almeida Júnior, Jesus Guinea
Frontiers in Microbiology|August 7, 2018
Comparison of Two Highly Discriminatory Typing Methods to Analyze <i>Aspergillus fumigatus</i> Azole ResistanceRocio Garcia-Rubio, Pilar Escribano, Ana Gomez, et al.
The Journal of Antimicrobial Chemotherapy|June 20, 2020
Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparatorsKarin Meinike Jørgensen, Jesus Guinea, Joseph Meletiadis, et al.
Journal of Clinical Microbiology|May 22, 2026
Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of <i>Aspergillus fumigatus</i> to echinocandins with the EUCAST E.Def 9.4Joseph Meletiadis, Maria Siopi, Karin Meinike Jørgensen, et al.
The Journal of Antimicrobial Chemotherapy|July 29, 2025
A multicentre study for determination of epidemiological cut-off values for Candida auris with EUCAST broth microdilution reference methodologyJoseph Meletiadis, Jesus Guinea, Sevtap Arikan-Akdagli, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2022
Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafunginMaiken Cavling Arendrup, Sevtap Arikan-Akdagli, Mariana Castanheira, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Mycopathologia|July 11, 2024
Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining ChallengesMaiken Cavling Arendrup, Jesus Guinea, Joseph Meletiadis
International Journal of Antimicrobial Agents|December 7, 2010
New antifungal agents for the treatment of candidaemiaPatricia Muñoz, Jesus Guinea, Loreto Rojas, et al.
International Journal of Antimicrobial Agents|December 17, 2008
Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new dataPatricia Muñoz, Jesus Guinea, Marta Torres Narbona, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 11, 2020
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by TrichophytonMaiken C Arendrup, Gunnar Kahlmeter, Jesus Guinea, et al.
Current Opinion in Infectious Diseases|November 3, 2017
Emerging multidrug-resistant Candida speciesArnaldo L Colombo, João N de Almeida Júnior, Jesus Guinea
Frontiers in Microbiology|August 7, 2018
Comparison of Two Highly Discriminatory Typing Methods to Analyze <i>Aspergillus fumigatus</i> Azole ResistanceRocio Garcia-Rubio, Pilar Escribano, Ana Gomez, et al.
The Journal of Antimicrobial Chemotherapy|June 20, 2020
Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparatorsKarin Meinike Jørgensen, Jesus Guinea, Joseph Meletiadis, et al.
Journal of Clinical Microbiology|May 22, 2026
Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of <i>Aspergillus fumigatus</i> to echinocandins with the EUCAST E.Def 9.4Joseph Meletiadis, Maria Siopi, Karin Meinike Jørgensen, et al.
The Journal of Antimicrobial Chemotherapy|July 29, 2025
A multicentre study for determination of epidemiological cut-off values for Candida auris with EUCAST broth microdilution reference methodologyJoseph Meletiadis, Jesus Guinea, Sevtap Arikan-Akdagli, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2022
Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafunginMaiken Cavling Arendrup, Sevtap Arikan-Akdagli, Mariana Castanheira, et al.
Pageof 3